Avista Healthcare Partners promotes three investment team members

Avista Healthcare Partners announced three promotions within its investment team on January 5. The New York-based private equity firm promoted Ryan Moran and Garrett Lustig to Partner and Elaine Tang to Principal.

Moran joined Avista in 2018 after working at Morgan Stanley Capital Partners and Bank of America Merrill Lynch. He holds a B.A. from The George Washington University and an M.B.A. from Harvard Business School. Moran currently serves as a director of Cosette Pharmaceuticals, GCM Holding Corporation, WellSpring Consumer Healthcare, and XIFIN.

Lustig has been with Avista since 2015, previously working in investment banking at Centerview Partners. He received a B.S. from Duke University and serves as a director of multiple companies including ACP Northern Holdings, EBi Bone Healing, eMolecules, Organogenesis (NASDAQ: ORGO), and Taconic Biosciences.

Tang joined Avista in 2022 from Partners Group, where she worked in private equity. She earned a B.A. from Wellesley College and an M.B.A. from Harvard Business School. Tang currently serves as a director of PK Benelux and Probo Medical.

"We are thrilled to recognize Ryan, Garrett, and Elaine for their outstanding contributions to Avista's success as well as their partnerships with our portfolio company management teams and Boards," said David Burgstahler, Managing Partner and Chief Executive Officer of Avista.

Founded in 2005, Avista Healthcare Partners focuses exclusively on healthcare investments and has invested over $10 billion in more than 50 healthcare businesses globally, according to the press release.

You May Also Be Interested In

• William Blair Starts Surrozen Inc. (SRZN) at Outperform
• Morgan Stanley Upgrades Merck (MRK) to Overweight
• BofA survey shows European fund managers eye growth despite caution